Wednesday, November 4, 2026Eastern Time · Updated through the dayRSS

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Novo Nordisk raises 2026 outlook as Q3 obesity sales jump 22%

TR

By Tom Reyes · Markets Editor

Nov 4 02:20 ETSource: Yahoo Finance

From the source

Novo Nordisk raises 2026 outlook as Q3 obesity sales jump 22%

Read at finance.yahoo.com

Source URL https://finance.yahoo.com/healthcare/articles/novo-nordisk-raises-2026-outlook-072039445.html

Prescribed peptides from $99/moSee all →